ScholarIQanswers from OpenAlex
Targeting miR-155 to Treat Experimental Scleroderma
PaperCitations, authors & open-access status
Targeting miR-155 to Treat Experimental Scleroderma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting miR-155 to Treat Experimental Scleroderma have?
ScholarIQcitation count
Targeting miR-155 to Treat Experimental Scleroderma has 74 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting miR-155 to Treat Experimental Scleroderma published?
ScholarIQyear
Targeting miR-155 to Treat Experimental Scleroderma has 2016 year in the ScholarIQ index.
What is the open-access status of Targeting miR-155 to Treat Experimental Scleroderma?
ScholarIQoa status
Targeting miR-155 to Treat Experimental Scleroderma has gold oa status in the ScholarIQ index.
What is the DOI of Targeting miR-155 to Treat Experimental Scleroderma?
ScholarIQdoi
The DOI for Targeting miR-155 to Treat Experimental Scleroderma is on the source record.
What is the PMID of Targeting miR-155 to Treat Experimental Scleroderma?
ScholarIQpmid
The PMID for Targeting miR-155 to Treat Experimental Scleroderma is on the source record.
What is the OpenAlex record for Targeting miR-155 to Treat Experimental Scleroderma?
ScholarIQopenalex
The OpenAlex for Targeting miR-155 to Treat Experimental Scleroderma is on the source record.